ciliacell
Commercial- Indications
- Rhinosinusitis, Otitis media effusive
Company intelligence / Profile preview
Nevia Bio
Haifa, Haifa, Israelneviabiotech.co.uk ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Commercial
01
Overview
Nevia Bio completed proof of concept for ovarian cancer detection using hundreds of patient samples, showing promising accuracy versus standard care. Ongoing clinical collaborations (including Mayo Clinic MedTech accelerator) and pipeline development for additional indications.
- Therapeutic areas
- OncologyWomen's Health
- Modalities
- DiagnosticPlatform-based
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Mayo Clinicadditional US academic/clinical centers
Beyond the preview
Go deeper on Nevia Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nevia Bio.